RCKT β€” ROCKET PHARMACEUTICALS INC

Ownership history in Point72 (DIFC) Ltd  Β·  2 quarters on record

This page tracks every 13F SEC filing in which Point72 (DIFC) Ltd reported a position in ROCKET PHARMACEUTICALS INC (RCKT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
0.01% (2025 Q2)
πŸ“Š Avg. % of fund
0.0%
πŸ“… First filed
2024 Q3
πŸ“… Last filed
2025 Q2
⏱ Quarters held
2
% of Fund (quarterly)    RCKT price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 2 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q2 ADDED 54,270 +54,073 +27448.2% 0.01% $133K $2.45
2024 Q3 INITIATED 197 β€” β€” 0.00% $4K $18.47

🏒 Other funds also holding RCKT

As of 2025 Q4 β€” sorted by position size

Monaco Asset Management SAM 3Y 1.82% Lion Point Capital, LP 3Y 7Y 1.56% M28 Capital Management LP 3Y 0.98% Newtyn Management, LLC 3Y 7Y 0.98% Amitell Capital Pte Ltd 3Y 0.7% MPM BioImpact LLC 3Y 0.64% RTW INVESTMENTS, LP 3Y 7Y 0.62% Prosight Management, LP 3Y 7Y 0.54% Opaleye Management Inc. 3Y 7Y 0.44% MONIMUS CAPITAL MANAGEMENT, LP 0.32%
← Back to Point72 (DIFC) Ltd Holdings